Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics
Clinical trial NCT03953300 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03953300
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-08
- Primary completion
- 2026-10-19
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.